Kimball Electronics reports Q1 FY2027 results and reiterates full‑year sales guidance at the high end

Kimball Electronics posted fiscal Q1 FY2027 net sales of about $391 million, a 7% year‑over‑year increase, driven by medical, industrial and automotive growth. Adjusted earnings per share were $0.25, while adjusted net income fell to $6.1 million versus $12.3 million a year earlier. The company reiterated its FY2027 sales guidance of $1.535 billion‑$1.560 billion, expecting results at the high end of that range, and highlighted integration of the Helvoet acquisition as a catalyst for future medical sales.

The high‑end guidance signals a stronger revenue outlook for investors, but the company warned that margins will be pressured in the near term by integration costs and a 66.1% effective tax rate in the quarter. The guidance range sets expectations for the full‑year top line and operating‑income targets.

  • 1Net sales for Q1 FY2027 were $391 million, up 7% year‑over‑year.
  • 2Medical sales in Q1 were $116 million, a 14% increase year‑over‑year.
  • 3Adjusted earnings per diluted share were $0.25 in Q1.
  • 4Adjusted net income in Q1 was $6.1 million, down from $12.3 million a year earlier.
  • 5Full‑year FY2027 sales guidance was reiterated at $1.535 billion‑$1.560 billion, with the company expecting results at the high end of the range.
  • 6Adjusted operating income in Q1 was $17 million, or 4.3% of net sales.

Sources